Trials / Unknown
UnknownNCT03704454
The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Legacy Health System · Academic / Other
- Sex
- Female
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 50 mg PYC and then placebo | 4 weeks on PYC, then 4 weeks on placebo |
| DIETARY_SUPPLEMENT | 100 mg PYC and then placebo | 4 weeks on PYC, then 4 weeks on placebo |
| DIETARY_SUPPLEMENT | Placebo and then 50 mg PYC | 4 weeks on placebo, then 4 weeks on PYC |
| DIETARY_SUPPLEMENT | Placebo and then 100 mg PYC | 4 weeks on placebo, then 4 weeks of PYC |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-09-15
- Completion
- 2020-09-15
- First posted
- 2018-10-12
- Last updated
- 2018-10-12
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03704454. Inclusion in this directory is not an endorsement.